| 摘要 |
The invention relates to a method to determine the Mg2+ and/or Ca2+ levels in a cerebrospinal fluid obtained from a mammal, wherein Mg2+ and/or Ca2+ levels are connected to an α-synucleinopathy associated disease or disorder as well as a kit to be used in said method.
|
